MENU
IDYA
AS OF
Dec 24 closing price
Price
$35.68
Change
+$0.27 (+0.76%)
Capitalization
3.13B
96 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IDYA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

IDEAYA Biosciences (IDYA) Ownership - Who owns IDEAYA Biosciences?

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
7000 Shoreline Court
Phone
+1 650 443-6209
Employees
124
Web
https://www.ideayabio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.13B
P/E Ratio
N/A
Total Cash
786.89M
Projected Growth
N/A
Total Debt
27.25M
Revenue
214.83M
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
8.98
Total Debt/Equity
N/A
Revenue/Share
2.44 USD as % of share price

Fundamentals

IDYA
Capitalization
3.13B
P/E Ratio
N/A
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
787M
Total Cash/Share
8.98
Total Debt
27.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.44%
Revenue
215M
ROE
N/A
Book Value
1.09B
P/B Ratio
2.86
Cash Flow
N/A
Earnings
-1.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
12.44
Current Revenue Per Employee
1586519.10
Dividends Per Share - Security
N/A
EBITDA
-204.84M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-13.26
Shares Held By Institutions
4.57B
Shares Outstanding - Current
87.7M
Total Liabilities
93.1M
Total Volume MTD
N/A
Value
1
Gain YTD
38.833
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IDYA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IDYA showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IDYA
A.I. Advisor
published General Information

General Information

an oncology-focused precision medicine company committed to the discovery and development of targeted cancer therapeutics for patient populations selected using molecular diagnostics.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7000 Shoreline Court
Phone
+1 650 443-6209
Employees
124
Web
https://www.ideayabio.com